Related Experiment Video
Updated: Apr 6, 2026

08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.0K
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Menghao Yin1, Hanruo Sun1, Yanan Li1
1School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.
Small (Weinheim an Der Bergstrasse, Germany)
|July 15, 2024
Summary
Messenger RNA (mRNA) therapy faces delivery challenges. Biomimetic vectors offer biocompatible solutions for effective in vivo mRNA delivery, advancing therapeutic applications.
Area of Science:
- Biomedical Engineering
- Therapeutic Delivery Systems
- Molecular Medicine
Background:
- Messenger RNA (mRNA) represents a promising therapeutic modality for diverse diseases.
- The clinical application of mRNA is hindered by its inherent instability and inefficient cellular uptake.
- Effective delivery systems are crucial for in vivo mRNA expression in target cells and tissues.
Purpose of the Study:
- To review biomimetic vector-based strategies for mRNA delivery.
- To discuss the advantages of biomimetic vectors over conventional delivery systems.
- To explore the challenges and future prospects of biomimetic mRNA delivery systems in the biomedical field.
Main Methods:
- Literature review of biomimetic vector-based mRNA delivery systems.
- Analysis of the properties and advantages of biomimetic vectors (biocompatibility, targeting).
- Discussion of current challenges and future directions in the field.
Main Results:
- Biomimetic vectors demonstrate high biocompatibility and tissue-specific targeting capabilities.
- These vectors show potential for efficient in vivo mRNA delivery, overcoming limitations of naked mRNA.
- The review synthesizes existing knowledge on biomimetic approaches for mRNA therapeutics.
Conclusions:
- Biomimetic vectors are a promising strategy for overcoming mRNA delivery hurdles.
- Further research into biomimetic vector design and application can significantly advance mRNA-based therapies.
- This review provides insights into the potential and challenges of biomimetic systems for future biomedical applications.
Related Concept Videos
Recombinant DNA
104.9K
Overview
104.9K
Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K

